片仔癀：拟2亿元投资大健康产业基金

Core Viewpoint - The company Pianzaihuang (600436) announced an investment of 200 million yuan in a health industry investment partnership, aiming to enhance its strategic development and core competitiveness in the medical sector [1] Investment Details - The investment will be made by the company's wholly-owned subsidiary, Zhangzhou Pianzaihuang Investment Management Co., Ltd., using self-owned or raised funds [1] - The target fundraising scale of the partnership is 1 billion yuan, with the company’s investment accounting for 20% of this amount [1] - The fund will primarily invest in the healthcare sector, including pharmaceuticals, medical devices, and health-related supply chains, with non-healthcare investments capped at 10% [1] Strategic Objectives - The investment aims to leverage professional institutional resources to accelerate the concentration of the pharmaceutical industry, strengthen industry chain integration, and enhance core competitiveness [1] - The fund is managed by CITIC Jinshi Capital, which has extensive experience and expertise in the healthcare sector [1] Related Transactions - This investment is conducted in conjunction with related parties, including Zhangzhou Pianzaihuang Asset Management Co., Ltd. and Zhangzhou Tourism Investment Group Co., Ltd., and is classified as a related party transaction without constituting a major asset restructuring [1] Company Performance - In the first quarter of 2025, the company achieved a total operating revenue of 3.142 billion yuan and a net profit attributable to the parent company of 1 billion yuan [1]